225 related articles for article (PubMed ID: 26642325)
1. Use of FabV-Triclosan Plasmid Selection System for Efficient Expression and Production of Recombinant Proteins in Escherichia coli.
Ali SA; Chew YW; Omar TC; Azman N
PLoS One; 2015; 10(12):e0144189. PubMed ID: 26642325
[TBL] [Abstract][Full Text] [Related]
2. Plasmid selection in Escherichia coli using an endogenous essential gene marker.
Goh S; Good L
BMC Biotechnol; 2008 Aug; 8():61. PubMed ID: 18694482
[TBL] [Abstract][Full Text] [Related]
3. FabV/Triclosan Is an Antibiotic-Free and Cost-Effective Selection System for Efficient Maintenance of High and Medium-Copy Number Plasmids in Escherichia coli.
Ali SA; Chew YW
PLoS One; 2015; 10(6):e0129547. PubMed ID: 26057251
[TBL] [Abstract][Full Text] [Related]
4. ucFabV Requires Functional Reductase Activity to Confer Reduced Triclosan Susceptibility in Escherichia coli.
Fischer TL; White RJ; Mares KF; Molnau DE; Donato JJ
J Mol Microbiol Biotechnol; 2015; 25(6):394-402. PubMed ID: 26683704
[TBL] [Abstract][Full Text] [Related]
5. A pestivirus DNA vaccine based on a non-antibiotic resistance Escherichia coli essential gene marker.
El-Attar LM; Scott S; Goh S; Good L
Vaccine; 2012 Feb; 30(9):1702-9. PubMed ID: 22212129
[TBL] [Abstract][Full Text] [Related]
6. Vibrio cholerae FabV defines a new class of enoyl-acyl carrier protein reductase.
Massengo-Tiassé RP; Cronan JE
J Biol Chem; 2008 Jan; 283(3):1308-1316. PubMed ID: 18032386
[TBL] [Abstract][Full Text] [Related]
7. A novel selection marker for efficient DNA cloning and recombineering in E. coli.
Jang CW; Magnuson T
PLoS One; 2013; 8(2):e57075. PubMed ID: 23437314
[TBL] [Abstract][Full Text] [Related]
8. The antibiotic resistance-free mammalian expression plasmid vector pPAL for development of third generation vaccines.
Alcolea PJ; Alonso A; Larraga V
Plasmid; 2019 Jan; 101():35-42. PubMed ID: 30529129
[TBL] [Abstract][Full Text] [Related]
9. Reduced Susceptibility to Antiseptics Is Conferred by Heterologous Housekeeping Genes.
Tansirichaiya S; Reynolds LJ; Cristarella G; Wong LC; Rosendahl K; Roberts AP
Microb Drug Resist; 2018 Mar; 24(2):105-112. PubMed ID: 28604259
[TBL] [Abstract][Full Text] [Related]
10. Triclosan resistance of Pseudomonas aeruginosa PAO1 is due to FabV, a triclosan-resistant enoyl-acyl carrier protein reductase.
Zhu L; Lin J; Ma J; Cronan JE; Wang H
Antimicrob Agents Chemother; 2010 Feb; 54(2):689-98. PubMed ID: 19933806
[TBL] [Abstract][Full Text] [Related]
11. FabV, the Unique Enoyl-Acyl Carrier Protein Reductase in
Li F; Deng J; Zhang Z; Wang C; Mao Y
Phytopathology; 2024 Apr; 114(4):780-791. PubMed ID: 37913555
[TBL] [Abstract][Full Text] [Related]
12. Triclosan Resistance in a Bacterial Fish Pathogen, Aeromonas salmonicida subsp. salmonicida, is Mediated by an Enoyl Reductase, FabV.
Khan R; Lee MH; Joo HJ; Jung YH; Ahmad S; Choi JH; Lee SW
J Microbiol Biotechnol; 2015 Apr; 25(4):511-20. PubMed ID: 25370725
[TBL] [Abstract][Full Text] [Related]
13. Effects of lysine 2-hydroxyisobutyrylation on bacterial FabI activity and resistance to triclosan.
Zheng Y; Dong H; Bai X; Cui H; Li MJ; Wu HY; Zhang K
Biochimie; 2021 Mar; 182():197-205. PubMed ID: 33485933
[TBL] [Abstract][Full Text] [Related]
14. A Novel Nonantibiotic,
Terrinoni M; Nordqvist SL; Källgård S; Holmgren J; Lebens M
Appl Environ Microbiol; 2018 Feb; 84(4):. PubMed ID: 29222103
[TBL] [Abstract][Full Text] [Related]
15. Signature gene expression profile of triclosan-resistant Escherichia coli.
Yu BJ; Kim JA; Pan JG
J Antimicrob Chemother; 2010 Jun; 65(6):1171-7. PubMed ID: 20410062
[TBL] [Abstract][Full Text] [Related]
16. Ligand- and Structure-Based Approaches of Escherichia coli FabI Inhibition by Triclosan Derivatives: From Chemical Similarity to Protein Dynamics Influence.
Kronenberger T; de Oliveira Fernades P; Drumond Franco I; Poso A; Gonçalves Maltarollo V
ChemMedChem; 2019 Dec; 14(23):1995-2004. PubMed ID: 31670463
[TBL] [Abstract][Full Text] [Related]
17. Interplay of SOS induction, recombinant gene expression, and multimerization of plasmid vectors in Escherichia coli.
Lee J; Kim HC; Kim SW; Kim SW; Hong SI; Park YH
Biotechnol Bioeng; 2002 Oct; 80(1):84-92. PubMed ID: 12209789
[TBL] [Abstract][Full Text] [Related]
18. A new vector for heterologous gene expression in Escherichia coli with increased stability in the absence of antibiotic.
Eguia FAP; Ramos HR; Kraschowetz S; Omote D; Ramos CRR; Ho PL; Carvalho E; Gonçalves VM
Plasmid; 2018 Jun; 98():22-30. PubMed ID: 30193910
[TBL] [Abstract][Full Text] [Related]
19. Escherichia coli enoyl-acyl carrier protein reductase (FabI) supports efficient operation of a functional reversal of β-oxidation cycle.
Vick JE; Clomburg JM; Blankschien MD; Chou A; Kim S; Gonzalez R
Appl Environ Microbiol; 2015 Feb; 81(4):1406-16. PubMed ID: 25527535
[TBL] [Abstract][Full Text] [Related]
20. Fitness costs associated with carriage of a large staphylococcal plasmid are reduced by subinhibitory concentrations of antiseptics.
LaBreck PT; Merrell DS
Microbiologyopen; 2020 Apr; 9(4):e1005. PubMed ID: 32053737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
